Plexus is in a powerful sustained uptrend, with the stock surging 96.4% over the past year, dramatically outperforming the S&P 500's 20.6% gain. The current price of $267.27 sits at 87% of its 52-week range ($115.35 low to $307.06 high), indicating the stock is trading near the upper end of its range but not yet at overbought extremes, suggesting strong momentum with room for further upside. The 1-year relative strength of +75.8% versus the S&P 500 underscores the stock's exceptional relative performance. Short-term momentum shows a conflicting picture: the stock has declined 3.0% over the past month while gaining 17.4% over the past three months. This 1-month pullback contrasts with the robust 1-year uptrend, potentially signaling a temporary consolidation or profit-taking phase rather than a trend reversal. The 1-month relative strength of -7.1% versus the S&P 500 confirms recent underperformance, but the 3-month relative strength of +6.3% suggests the longer-term trend remains intact. The 52-week high of $307.06 represents immediate resistance, while the 52-week low of $115.35 provides a distant support level. A breakout above $307.06 would signal a continuation of the uptrend, while a breakdown below the recent low of $255.94 (July 7 close) could indicate further weakness. With a beta of 0.88, Plexus is slightly less volatile than the overall market, offering a relatively defensive profile within the technology sector, which is favorable for risk-adjusted positioning.

Plexus's revenue trajectory is accelerating, with the most recent quarter (Q1 FY2026, ended January 3, 2026) reporting $1.070 billion, up 9.6% year-over-year from $976 million in the prior-year quarter. This marks a clear acceleration from the 1.4% YoY growth in Q4 FY2025 and the 5.4% growth in Q3 FY2025, driven by strength in the Asia Pacific segment ($612 million, 57% of revenue) and Americas ($345 million, 32% of revenue). The sequential revenue growth from Q4 FY2025's $1.058 billion to Q1 FY2026's $1.070 billion confirms the upward momentum, supporting the investment case for cyclical recovery and market share gains. Profitability is improving, with net income of $41.2 million in Q1 FY2026, up from $37.3 million in the year-ago quarter, and diluted EPS of $1.51 versus $1.34. Gross margin has been relatively stable around 9.9-10.3% over the past four quarters, with Q1 FY2026 at 9.9%, slightly below the 10.3% in Q1 FY2025. Operating margin improved to 5.1% from 4.8% a year ago, reflecting better operating leverage. Net margin expanded to 3.8% from 3.8% (flat), but the absolute net income growth demonstrates the company's ability to convert revenue growth into profits. Plexus maintains a strong balance sheet with a debt-to-equity ratio of 0.12 and a current ratio of 1.58, indicating ample liquidity. Free cash flow (FCF) was negative $50.6 million in Q1 FY2026, primarily due to working capital investments (inventory build of $74.9 million and accounts receivable increase of $24.9 million), but trailing twelve-month FCF stands at $76.3 million. Return on equity (ROE) of 11.9% and return on assets (ROA) of 4.3% demonstrate efficient capital allocation, while the low debt levels provide financial flexibility.